Discovery Life Sciences is the global market leader in biospecimen procurement, analysis, distribution, and scientific services for the pharmaceutical, biotechnology and diagnostics industries. Discovery leverages deep scientific expertise and consultative services, combined with the largest repository of research-quality biospecimens—available and processed for analysis—to accelerate the discovery, research, and development of novel biomarkers, drug candidates, and diagnostics.
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con
Colorectal and Lung Tumoroids are Now Available
NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter
Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions
NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con